Impact of metabolic syndrome on the viability of human spermatozoa: a cross-sectional descriptive study in men from infertile couples

Table 3 Sperm survival test in men with and without metabolic syndrome

SST	Total (n = 195)	Metabolic syndrome		P-value^a
SST	Total (n = 195)	MetS (n = 47)	Non-MetS (n = 148)	P-value^a
PR motility (%)
PR-0 h	76.03 ± 10.52	76.53 ± 9.65	75.87 ± 10.81	0.71
PR-24 h	30.99 ± 15.80	28.81 ± 14.96	31.69 ± 16.05	0.28
Viability (%)
Viable-0 h	86.78 ± 6.91	86.53 ± 7.04	86.86 ± 6.89	0.77
Viable-24 h	54.98 ± 17.33	53.15 ± 17.24	55.57 ± 17.38	0.41
Result of SST [n(%)]
Normal	82 (42.1%)	13 (27.7%)	69 (46.6%)	0.02
Abnormal	113 (57.9%)	34 (72.3%)	79 (53.4%)	0.02
SMI-24 h (%)	40.20 ± 18.60	36.87 ± 16.47	41.24 ± 19.16	0.16
SVI-24 h (%)	62.68 ± 17.34	60.79 ± 17.01	63.28 ± 17.57	0.39

PR progressive; SMI sperm motility index; SST sperm survival test; SVI sperm vitality index
Sperm parameters were assessed after prepared by gradient density centrifugation
Values were expressed as mean ± SD and the percentage
^a Comparison was performed between men with and without MetS using the independent-samples t test and the chi-square test

ISSN: 2051-4190